title: Deprenyl and the issue of neuroprotection.
authors.forename: F J
authors.initials: FJ
authors.lastname: Vingerhoets
authors.forename: R J
authors.initials: RJ
authors.lastname: Uitti
authors.forename: D B
authors.initials: DB
authors.lastname: Calne
mesh_terms: D000975:Antioxidants / Q000008:administration & dosage*; D002470:Cell Survival / Q000187:drug effects; D002986:Clinical Trials as Topic; D004185:Disability Evaluation; D004334:Drug Administration Schedule; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D009474:Neurons / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology; D012642:Selegiline / Q000008:administration & dosage*; D013378:Substantia Nigra / Q000187:drug effects; D014810:Vitamin E / Q000008:administration & dosage
chemical_list: D000975:Antioxidants; D014810:Vitamin E; D012642:Selegiline; D007980:Levodopa